Vitamin D and parathyroid hormone in relation to bone health in Croatian women.

IF 2.8 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Archives of Osteoporosis Pub Date : 2018-06-24 DOI:10.1007/s11657-018-0483-z
Irena Keser, Selma Cvijetić, Martina Bituh, Ivana Rumora Samarin, Jasminka Z Ilich, Irena Colić Barić, Ivana Rumbak
{"title":"Vitamin D and parathyroid hormone in relation to bone health in Croatian women.","authors":"Irena Keser,&nbsp;Selma Cvijetić,&nbsp;Martina Bituh,&nbsp;Ivana Rumora Samarin,&nbsp;Jasminka Z Ilich,&nbsp;Irena Colić Barić,&nbsp;Ivana Rumbak","doi":"10.1007/s11657-018-0483-z","DOIUrl":null,"url":null,"abstract":"<p><p>In N = 400 women (46.9 ± 15.5 years), the prevalence of severe (< 25 nmol/l) and mild (≥ 25 and < 50 nmol/l) 25(OH)D deficiency was 7 and 32.2%, respectively, while 60.8% women had adequate status. Serum iPTH increased (> 37.0 pg/ml) when 25(OH)D was < 46.9 nmol/l. BMD was not significantly lower in the participants with iPTH > 37.0 pg/ml.</p><p><strong>Purpose: </strong>Bone mineral density (BMD) is affected by serum 25-hydroxyvitamin D (25(OH)D) and intact parathyroid hormone (iPTH). Our objective was to analyze the association between serum 25(OH)D and iPTH and their mutual regulatory influence on BMD in women with 25(OH)D deficiency. We also attempted to establish a threshold for the serum 25(OH)D below which serum iPTH increases.</p><p><strong>Methods: </strong>The participants were 400 generally healthy women (46.9 ± 15.5 years) recruited from local communities. BMD was measured by dual-energy X-ray absorptiometry, and serum 25(OH)D, iPTH, calcium, phosphorus, alkaline phosphatase, osteocalcin, and C-telopeptide (CTX) were analyzed from the fasting blood samples. Multivariate regression models were used to investigate the relationships among serum 25(OH)D, iPTH, and BMD.</p><p><strong>Results: </strong>Serum iPTH increased when 25(OH)D concentrations were below 46.9 nmol/l. Severe 25(OH)D deficiency (< 25 nmol/l) was found in 7% of the participants and was associated with significantly higher iPTH compared to participants with serum 25(OH)D ≥ 25 nmol/l. BMD was negatively associated with iPTH only in the group with severe 25(OH)D deficiency. However, BMD was not significantly lower in the participants with severe 25(OH)D deficiency compared to those with mild deficiency or with adequate status.</p><p><strong>Conclusions: </strong>Our results showed that threshold level of 25(OH)D below which iPTH started to rise was 46.9 nmol/l. There was no negative impact of iPTH on BMD or bone turnover markers in women with severe 25(OH)D deficiency. This might be due to the relatively young age of our participants in whom the unfavorable effect of 25(OH)D deficiency on bone might have not yet appeared.</p>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":"13 1","pages":"69"},"PeriodicalIF":2.8000,"publicationDate":"2018-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11657-018-0483-z","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Osteoporosis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11657-018-0483-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 4

Abstract

In N = 400 women (46.9 ± 15.5 years), the prevalence of severe (< 25 nmol/l) and mild (≥ 25 and < 50 nmol/l) 25(OH)D deficiency was 7 and 32.2%, respectively, while 60.8% women had adequate status. Serum iPTH increased (> 37.0 pg/ml) when 25(OH)D was < 46.9 nmol/l. BMD was not significantly lower in the participants with iPTH > 37.0 pg/ml.

Purpose: Bone mineral density (BMD) is affected by serum 25-hydroxyvitamin D (25(OH)D) and intact parathyroid hormone (iPTH). Our objective was to analyze the association between serum 25(OH)D and iPTH and their mutual regulatory influence on BMD in women with 25(OH)D deficiency. We also attempted to establish a threshold for the serum 25(OH)D below which serum iPTH increases.

Methods: The participants were 400 generally healthy women (46.9 ± 15.5 years) recruited from local communities. BMD was measured by dual-energy X-ray absorptiometry, and serum 25(OH)D, iPTH, calcium, phosphorus, alkaline phosphatase, osteocalcin, and C-telopeptide (CTX) were analyzed from the fasting blood samples. Multivariate regression models were used to investigate the relationships among serum 25(OH)D, iPTH, and BMD.

Results: Serum iPTH increased when 25(OH)D concentrations were below 46.9 nmol/l. Severe 25(OH)D deficiency (< 25 nmol/l) was found in 7% of the participants and was associated with significantly higher iPTH compared to participants with serum 25(OH)D ≥ 25 nmol/l. BMD was negatively associated with iPTH only in the group with severe 25(OH)D deficiency. However, BMD was not significantly lower in the participants with severe 25(OH)D deficiency compared to those with mild deficiency or with adequate status.

Conclusions: Our results showed that threshold level of 25(OH)D below which iPTH started to rise was 46.9 nmol/l. There was no negative impact of iPTH on BMD or bone turnover markers in women with severe 25(OH)D deficiency. This might be due to the relatively young age of our participants in whom the unfavorable effect of 25(OH)D deficiency on bone might have not yet appeared.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
维生素D和甲状旁腺激素与克罗地亚妇女骨骼健康的关系。
在N = 400名女性(46.9±15.5岁)中,25(OH)D为37.0 pg/ml时,重度(37.0 pg/ml)患病率。目的:骨密度(BMD)受血清25-羟基维生素D (25(OH)D)和完整甲状旁腺激素(iPTH)的影响。我们的目的是分析血清25(OH)D和iPTH之间的关系,以及它们对25(OH)D缺乏症女性骨密度的相互调节影响。我们还试图建立血清25(OH)D的阈值,低于该阈值,血清iPTH升高。方法:从当地社区招募400名健康女性(46.9±15.5岁)。采用双能x线骨密度仪测定骨密度,测定空腹血25(OH)D、iPTH、钙、磷、碱性磷酸酶、骨钙素、c -端肽(CTX)含量。采用多元回归模型探讨血清25(OH)D、iPTH和BMD之间的关系。结果:25(OH)D浓度低于46.9 nmol/l时,血清iPTH升高。结论:iPTH开始升高的25(OH)D阈值为46.9 nmol/l。iPTH对严重25(OH)D缺乏症妇女的骨密度或骨转换指标没有负面影响。这可能是由于我们的参与者相对年轻,25(OH)D缺乏对骨骼的不利影响可能尚未出现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Archives of Osteoporosis
Archives of Osteoporosis ENDOCRINOLOGY & METABOLISMORTHOPEDICS -ORTHOPEDICS
CiteScore
5.50
自引率
10.00%
发文量
133
期刊介绍: Archives of Osteoporosis is an international multidisciplinary journal which is a joint initiative of the International Osteoporosis Foundation and the National Osteoporosis Foundation of the USA. The journal will highlight the specificities of different regions around the world concerning epidemiology, reference values for bone density and bone metabolism, as well as clinical aspects of osteoporosis and other bone diseases.
期刊最新文献
The effect of OsteoStrong compared to dynamic multicomponent exercise on bone strength in older women: the BONEMORE non-inferiority randomized controlled trial. Zoledronic acid for chronic kidney disease-associated osteoporosis. Clinical features of osteoporosis in patients with type 1 and type 2 diabetes in Türkiye: A nationwide study. Sex-specific association between osteoporosis and cataracts: UK Biobank and Hong Kong Osteoporosis Study. TSH suppression attenuates the early efficacy of zoledronic acid in osteoporosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1